WuXi Biologics Competitors and Similar CompaniesClear all
WuXi Biologics's competitors and similar companies include Evotec, Catalent, Samsung Biologics and Fujifilm Diosynth Biotechnologies.
 WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  Samsung Biologics Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | ||
Founding Date | Founding Date 2010 | Founding Date 1993 | Founding Date 2007 | Founding Date 2011 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Hamburg, DE HQ Orth An Der Donau, AT Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE see more | Locations Somerset, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Incheon, KR HQ Boston, US Ridgefield Park, US South San Francisco, US | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US |
Employees | Employees 12,435 | Employees 5,007 | Employees 16,9005% decrease | Employees 4,523 | Employees 5,0151% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 10.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥17b (FY, 2023) | Revenue (est.) €781.4m (FY, 2023) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) ₩3.7t (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥8.8b (FY, 2023) | Cost of goods €564.3m (FY, 2023) | Cost of goods $3.4b (FY, 2024) | Cost of goods ₩1.9t (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥8.4b (FY, 2023) | Gross profit €281.9m (FY, 2023) | Gross profit $953m (FY, 2024) | Gross profit ₩1.8t (FY, 2023) | Gross profit N/A |
Net income | Net income ¥3.6b (FY, 2023) | Net income (€83.9m) (FY, 2023) | Net income ($1b) (FY, 2024) | Net income ₩857.7b (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Backlog | Backlog $18.5b (H1, 2022) | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog N/A | Backlog N/A |
Customers | Customers N/A | Customers 781 (FY, 2023) | Customers 1.2 k (FY, 2023) | Customers N/A | Customers N/A |
Products | Products N/A | Products 140 (FY, 2023) | Products 8 k (FY, 2023) | Products N/A | Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 993.6m | Total funding raised $ 650m | Total funding raised N/A | Total funding raised $ 850m |
For sources of this data, please see the company profile
View Company Profiles
Evotec
HQ
Hamburg, DE
Employees
5,007
Evotec is a biotechnology company that provides drug discovery and development services.
View companyCatalent
HQ
Somerset, US
Employees
16,900↓ 5% decrease
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companySamsung Biologics
HQ
Incheon, KR
Employees
4,523
Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View company